TUG1 and non-small cell lung carcinoma: Our study recruited 108 pathologically diagnosed NSCLC patients who received DDP-based chemotherapy and found that low expression levels of TUG1 may be associated with the resistance to DDP-based chemotherapy and poor overall survival.